PreveCeutical Medical Inc (18H) — Capital Reinvestment Ratio

Latest as of September 2020: 0.04x

PreveCeutical Medical Inc (18H) has a Capital Reinvestment Ratio of 0.04x as of September 2020, meaning it reinvests 0% of its operating cash flow (€520.22K) in capital expenditures (€21.18K). Also explore PreveCeutical Medical Inc equity growth rate to track the company's year-over-year net asset growth rate.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

€520.22K

EUR

Capital Expenditures

€21.18K

EUR

Data as of

Sep 2020

Most recent filing

PreveCeutical Medical Inc Capital Reinvestment Ratio (2020–2020)

This chart tracks PreveCeutical Medical Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 18H operating cash flow.

Annual Capital Reinvestment Ratio for PreveCeutical Medical Inc (2020–2020)

Year-by-year Capital Reinvestment Ratio for PreveCeutical Medical Inc from 2020 to 2020. See PreveCeutical Medical Inc (18H) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2020	0.04x	€64.59K	€2.65K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow